Gary Brecka

I like that.

And it's a very different day today than it was back in 2020 when the vaccine was a good match for the circulating strain at the time.

There was low natural immunity levels.

We didn't understand a lot of what we know now.

And we recognize that myocarditis is a real complication that is seen in young men and that some individuals' children have died from it.

So we need all the information to be out there.

And our promise has been that we're not going to

take away anybody's vaccines, but we are going to provide information so that people can make their decisions.

We at the FDA have a simple job, and that is when companies present data, we decide whether or not that data supports the claims they want to make about their products.

That's our job.

It's pretty simple.

At the CDC, they decide what vaccines to recommend.

And I know that there's an ongoing evaluation that is going on to look at that.

And how in lockstep are you with the CDC?

I mean, we really have different roles, but we do have a lot of conversations.

And so we do an intensive review of the data, and sometimes we share the results of that directly.

So for example, there is an mRNA flu shot

mRNA vaccine technology is being used for other things now.

Our philosophy is, that's great, let's see the data, and if something works, we will do what we do at the FDA, and that is approve it if the benefits outweigh the risks.

Right.